Carmell Corp financial data

Symbol
CTCX, CTCXW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
2403 Sidney Street, Suite 300, Pittsburgh, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
ALPHA HEALTHCARE ACQUISITION CORP III (to 7/20/2023)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 129 % +68.5%
Debt-to-equity 333 %
Return On Equity -141 % -273%
Return On Assets -32.5 % -57.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20.9M shares -9.43%
Common Stock, Shares, Outstanding 20.9M shares -9.43%
Entity Public Float 149T USD 0%
Common Stock, Value, Issued 2.09K USD -9.4%
Weighted Average Number of Shares Outstanding, Basic 20.9M shares +12.2%
Weighted Average Number of Shares Outstanding, Diluted 20.9M shares +12.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 20.5K USD
Research and Development Expense 208K USD -79.1%
Selling and Marketing Expense 120K USD
Operating Income (Loss) -4.32M USD +54.2%
Nonoperating Income (Expense) -5.42M USD +76.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.75M USD +47.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -6.3M USD +69.6%
Earnings Per Share, Basic 5.63 USD/shares +77.4%
Earnings Per Share, Diluted 5.63 USD/shares +77.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.14M USD -85.7%
Inventory, Net 97.9K USD -99%
Other Assets, Current 17.6K USD
Assets, Current 1.88M USD -95.2%
Property, Plant and Equipment, Net 131K USD -54.7%
Operating Lease, Right-of-Use Asset 405K USD -53.2%
Goodwill 19.3M USD
Assets 2.44M USD -97%
Accounts Payable, Current 4.21M USD -76.3%
Accrued Liabilities, Current 2.82M USD +298%
Liabilities, Current 6.17M USD -83.6%
Deferred Income Tax Liabilities, Net 7.84M USD
Operating Lease, Liability, Noncurrent 333K USD -55.1%
Liabilities 6.51M USD -89.4%
Retained Earnings (Accumulated Deficit) -68M USD -10.2%
Stockholders' Equity Attributable to Parent -4.06M USD -119%
Liabilities and Equity 2.44M USD -97%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.08M USD -126%
Net Cash Provided by (Used in) Financing Activities -196K USD -152%
Net Cash Provided by (Used in) Investing Activities -749K USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 20.9M shares -9.43%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.14M USD -84%
Interest Paid, Excluding Capitalized Interest, Operating Activities 11.6K USD -68.8%
Deferred Tax Assets, Valuation Allowance 12.1M USD +22.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.33 pure -90%
Deferred Tax Assets, Gross 12.1M USD +22.1%
Operating Lease, Liability 813K USD
Lessee, Operating Lease, Liability, to be Paid 973K USD
Property, Plant and Equipment, Gross 1.06M USD
Operating Lease, Liability, Current 86.2K USD -38.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 205K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 205K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 160K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 205K USD
Deferred Tax Assets, Operating Loss Carryforwards 8.78M USD +14.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 205K USD
Operating Lease, Payments 34.8K USD +10.9%
Additional Paid in Capital 0 USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 402K USD
Depreciation, Depletion and Amortization 88.6K USD -22.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 623K USD -21.9%
Interest Expense 7.12K USD -60.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%